Dr. Reddy’s Laboratories announces the launch of Pregabalin Capsules in the U.S. Market
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together…
Pharmaceuticals, Biotechnology and Life Sciences
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together…
With its long-standing commitment to patients, the designation makes City of Hope the highest ranked cancer hospital in the West…
$13 Million Bill & Melinda Gates Foundation Grant to Fund Development Program to Address Lack of Family Planning Options Globally…
VANCOUVER, British Columbia–(BUSINESS WIRE)–Sproutly Canada, Inc. (CSE: SPR) (FRA: 38G) (OTCQB: SRUTF) (“Sproutly” or the “Company”) today announced the Company’s…
ATLANTA–(BUSINESS WIRE)–QUE Oncology, a clinical-stage biotechnology company developing a novel treatment for breast cancer patients suffering debilitating hot flashes, today…
Kraig Labs shareholders approve all ballot proposals ANN ARBOR, Mich.–(BUSINESS WIRE)–$KBLB #KBLB–Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading…
WOODCLIFF LAKE, N.J.–(BUSINESS WIRE)–Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced that the Company will release its…
Revenue of $214.1 million in the second quarter of 2019 increased 25.8% from revenue of $170.1 million for the comparable…
HAYWARD, Calif.–(BUSINESS WIRE)–Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, today announced that members…
BOSTON–(BUSINESS WIRE)–Verastem, Inc. (Nasdaq: VSTM) (Verastem Oncology or the Company), a biopharmaceutical company focused on developing and commercializing medicines seeking…